subscribeSubscribe
price-trendAsk Us
PaxMedica To Provide Immediate PAX-101 IV Suramin Access

PaxMedica To Provide Immediate PAX-101 IV Suramin Access
GLOBENEWSWIRE
23 Apr 2024
Share Share
PaxMedica Receives Emergency IV Suramin Request from African Health Ministry

PaxMedica Receives Emergency IV Suramin Request from African Health Ministry
GLOBENEWSWIRE
16 Apr 2024
Share Share
SAHPRA grants approval to begin trial of PaxMedica’s long Covid-19 therapy

SAHPRA grants approval to begin trial of PaxMedica’s long Covid-19 therapy
CLINICALTRIALSARENA
10 Jan 2022
Share Share
PaxMedica Plans to Initiate Phase 1B Study for PAX-101 in COVID-19 Syndrome

PaxMedica Plans to Initiate Phase 1B Study for PAX-101 in COVID-19 Syndrome
PRNEWSWIRE
07 Jan 2022
Share Share
IV suramin may be a promising autism treatment, shows Phase II study

IV suramin may be a promising autism treatment, shows Phase II study
Anna Begley EUROPEANPHARMACEUTICALREVIEW
29 Oct 2021
Share Share